Beacon Clinical Research

Executive Summary

Beacon Clinical Research, founded in 2005 and headquartered in Quincy, Massachusetts, is a leading clinical research center serving the Boston area. The company has conducted hundreds of clinical trials for top life science companies, focusing on conditions such as depression, chronic pain, fibromyalgia, overactive bladder, acne, diabetes, and osteoarthritis. With a team of highly skilled and compassionate physicians, Beacon Clinical Research offers patients access to cutting-edge treatments while providing sponsors with efficient and high-quality trial execution. As a private entity, the company has maintained a steady presence in the competitive New England clinical research landscape. While no financial disclosures are available, its longevity and extensive trial history suggest a strong operational track record. The company is well-positioned to capitalize on the growing demand for decentralized and site-based clinical trials, particularly in therapeutic areas with high patient burden. Key growth drivers include potential expansion into new therapeutic indications, partnerships with emerging biotech firms, and adoption of digital health tools to enhance patient recruitment and retention. However, as a private site, its visibility is limited, and its growth may be constrained by competitive pressures from larger CROs and academic medical centers.

Upcoming Catalysts (preview)

• Q3 2026New partnership with a top-20 pharma for a late-stage CNS trial60% success
• Q4 2026Expansion of Quincy facility to increase patient capacity50% success
• Q1 2027Launch of a virtual trial platform to expand reach40% success